FORTE BIOSCIENCES INC FBRX 深 滬
已收盤 07-10 16:00:00 美东时间
43.92
+7.220
+19.67%
華盛通- 最 高45.36
- 今 開37.94
- 成交量 319.03万股
- 最 低 37.50
- 昨 收 36.70
- 總市值 8.99亿
- 52周最高 45.36
- 市盈率 靜 --
- 換手率 15.58%
- 52周最低 9.10
- 委 比 75.88%
- 總股本 2047.88万
- 歷史最高 6732.375
- 量 比 2.42
- 振 幅 21.42%
- 歷史最低 4.90
- 每 手 1
- 風險率 7.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股牛股 | 生物制药公司FBRX大涨逾78%！关键药物研究成果积极；地热电力公司FRVO股价劲升16%
生物制药公司FBRX大涨逾78%！关键药物研究成果积极；地热电力公司FRVO股价劲升16%，地热开发项目取得重要进展；贵金属概念股TXG涨15%！此前获大摩大幅上调目标价>>
07-10 19:22
Aehr Test Systems, Lam Research, Applied Materials And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining more than 150 points on Thursday. Shares of Aehr Test Systems (NASDAQ:AEHR) rose sharply during Thursday’s session after the company announced it received an additional follow-on production order from its lead silicon photonics customer for ...
07-09 22:01
Forte Biosciences Reports Results From FB102 Double-Blind Placebo-Controlled Phase 1b Study In Vitiligo
Statistically Significant FB102 Benefit Observed By Day 64 and Continued through Week 24 FB102-Treated Subjects Continued Improving Through Week 24 After Completion of the 12-Week Treatment Period Supporting FB102 Mechanistic Modulation of Both IL-2– and IL-15–Dependent Pathogenic T-cell Biology whi...
07-09 20:08
Forte Biosciences Files $500M Shelf Registration For Potential Issuance Of Common Stock, Preferred Stock, Debt Securities, Warrants, And Other Securities From Time To Time
Forte Biosciences, Inc.$500,000,000Common StockPreferred StockDebt SecuritiesDepositary SharesWarrantsSubscription RightsPurchase ContractsUnits We may issue securities from time to time in one or more offerings, in
06-03 04:49
Forte Biosciences Q1 EPS $(1.24) Misses $(1.19) Estimate
Forte Biosciences (NASDAQ:FBRX) reported quarterly losses of $(1.24) per share which missed the analyst consensus estimate of $(1.19) by 4.2 percent. This is a 9.49 percent increase over losses of $(1.37) per share from
05-11 21:06
美股牛股 | ZNTL飙升60%，卵巢癌临床试验获重大突破；IVVD大涨31%
ZNTL飙升60%，卵巢癌临床试验获重大突破；IVVD大涨31%，就儿科临床研究与FDA达成一致；EOSE大涨近30%，Q1财报强劲，营收创新高>>
04-10 19:22
Forte Biosciences shares are trading lower after the company announced a proposed public offering.
Forte Biosciences shares are trading lower after the company announced a propos...
04-09 04:18
Forte Biosciences Reveals Proposed Public Offering; No Size Disclosed
Forte Biosciences, Inc. (NASDAQ:FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced that it has commenced an underwritten public offering of shares of
04-09 04:03
Forte Biosciences Q4 EPS $(1.45) Misses $(1.06) Estimate
Forte Biosciences (NASDAQ:FBRX) reported quarterly losses of $(1.45) per share which missed the analyst consensus estimate of $(1.06) by 37.05 percent. This is a 22.88 percent decrease over losses of $(1.18) per share
04-01 05:21
美股牛股 | 存储再度狂飙！Sandisk大涨逾15%；生物技术公司TWST涨约14%，Q1业绩超预期
存储再度狂飙！Sandisk大涨逾15%，伯恩斯坦上调目标价至1000美元；生物技术公司TWST涨约14%，Q1业绩超预期；欧朋涨超13%，此前上调Q4收入预期指引>>
02-03 15:29
